Target intelligence / Profile preview

DNA synthesis pathways

Molecular classification
Other (biochemical pathway, not a specific enzyme, receptor, or protein)
01

Overview

DNA synthesis pathways comprise the set of cellular biochemical routes and regulatory mechanisms that enable cells to replicate and repair DNA. The process is tightly regulated by the cell cycle and involves a complex assembly of proteins—including DNA polymerases, helicases, primases, topoisomerases, and enzymes for nucleotide biosynthesis. DNA synthesis is essential for genome stability and cellular proliferation; its dysregulation or targeted inhibition underlies the mechanism of action for many anticancer and antibiotic drugs. This term describes a collection of enzymatic and regulatory processes responsible for the synthesis and replication of DNA in cells, rather than a single molecule, protein, or canonical therapeutic target. It is a functional/processual classification and not a single molecular target. For structured data purposes, this entry is not a single canonical druggable target, but a process involving multiple targets.

Other names
DNA replication pathwayDNA biosynthesis pathwayDNA replication machineryDNA replication processes
02

Mechanism of action

Mechanisms of action are not applicable to the pathway as a whole, but depend on the specific enzyme or process targeted within the pathway. Examples include: inhibition of DNA polymerases (preventing chain elongation), inhibition of ribonucleotide reductase (blocking deoxyribonucleotide production), and inhibition of thymidylate synthase (preventing dTMP formation).

03

Biological functions

Genome duplicationCell cycle progressionCell divisionDNA repair
04

Disease associations

Cancer (altered DNA replication associated with tumorigenesis)Infection (targeted by antivirals/antibacterials)Genetic instability disorders
05

Safety considerations

Bone marrow suppressionGastrointestinal toxicityAlopecia (due to effect on rapidly dividing cells)Mutagenesis or teratogenicity (due to DNA damage)
06

Interacting drugs

Gemcitabine (nucleoside analog)

3 more in the full profile.

07

Biomarkers

No universal biomarkers for the pathway as a whole; specific enzyme levels (e.g., thymidylate synthase, DNA polymerase subunits) may be used in research or clinical trials.

Beyond the preview

Go deeper on DNA synthesis pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA synthesis pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call